Abiraterone Race in Metastatic Castrate-resistant Prostate Cancer
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Daniel George, MD
Duke University
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
14 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Birmingham Va Medical Center
Birmingham, Alabama, United States
- Tulane Cancer Center
New Orleans, Louisiana, United States
- Karmanos Cancer Institute
Detroit, Michigan, United States
- University of North Carolina
Chapel Hill, North Carolina, United States
- Duke University Medical Center
Durham, North Carolina, United States
- Maria Parham Medical Center
Henderson, North Carolina, United States
- Scotland Memorial Hospital
Laurinburg, North Carolina, United States
- Southeastern Regional
Lumberton, North Carolina, United States
- Duke Raleigh Hospital
Raleigh, North Carolina, United States
- W. G. 'Bill' Hefner Va Medical Center
Salisbury, North Carolina, United States
- Johnston Memorial Hospital
Smithfield, North Carolina, United States
- Wake Forest University
Winston-Salem, North Carolina, United States
- Spartanburg Regional
Spartanburg, South Carolina, United States
- Virginia Oncology Associates
Hampton, Virginia, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 31 Oct 2013
- Primary completion
- 8 Oct 2019
- Completion
- 8 Oct 2019
- Last update posted
- 9 Dec 2020
- Registered enrollment
- 100
- Registry id
- NCT01940276
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.